Private equity firm Permira has bought a controlling stake in Italy-based pharmaceuticals company Kedrion Biopharma, onto which it will bolt on Bio Products Laboratory (BPL), with reinvestment from Kedrion’s controlling Marcucci family and PE peer FSI.
